Novel Insights and Therapeutics for Parkinson’s disease

Parkinson’s disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinson’s disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.


  • Levodopa
  • Clinical trial for Parkinson,
  • Outcome of clinical trials in PSP
  • Therapeutic options for mood
  • Cognition and Psychosis

Related Conference of Novel Insights and Therapeutics for Parkinson’s disease

March 27-28, 2024

6th International Conference on Digital Health

London, UK
April 24-25, 2024

35th European Heart and Heart Failure Congress

Paris, France
June 21-22, 2024

52nd Global Nursing & Healthcare Conference

Rome, Italy
September 09-10, 2024

3rd Global Summit on Physiology and Metabolism of Thyroid

Paris, France
September 18-19, 2024

29th International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
September 19-20, 2024

20th Global Biomarkers and Clinical Research Summit

Amsterdam, Netherlands
September 24-25, 2024

5th Global Summit on Public Health

Paris, France

Novel Insights and Therapeutics for Parkinson’s disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in